SO
TGTX icon

STRS Ohio’s TG Therapeutics TGTX Stock Holding History

STRS Ohio’s Portfolio TGTX Stock Details TGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.07M Buy
19,500
+10,800
+124% +$442K ﹤0.01% 703
2026
Q1 		$289K Hold
8,700
– – ﹤0.01% 1336
2025
Q4 		$259K Sell
8,700
-6,800
-44% -$222K ﹤0.01% 1405
2025
Q3 		$560K Sell
15,500
-8,900
-36% -$293K ﹤0.01% 1002
2025
Q2 		$878K Buy
24,400
+4,500
+23% +$168K ﹤0.01% 970
2025
Q1 		$785K Sell
19,900
-4,100
-17% -$138K ﹤0.01% 966
2024
Q4 		$722K Sell
24,000
-11,400
-32% -$327K ﹤0.01% 977
2024
Q3 		$828K Sell
35,400
-2,600
-7% -$56.8K ﹤0.01% 979
2024
Q2 		$676K Buy
38,000
+29,100
+327% +$464K ﹤0.01% 1039
2024
Q1 		$135K Sell
8,900
-8,600
-49% -$137K ﹤0.01% 1640
2023
Q4 		$298K Buy
+17,500
New +$203K ﹤0.01% 1459
2023
Q3 		– Sell
-8,000
Closed -$198K – 2045
2023
Q2 		$198K Buy
+8,000
New +$207K ﹤0.01% 1590
2022
Q3 		– Sell
-26,900
Closed -$114K – 2087
2022
Q2 		$114K Buy
26,900
+4,800
+22% +$30K ﹤0.01% 1742
2022
Q1 		$210K Hold
22,100
– – ﹤0.01% 1699
2021
Q4 		$419K Sell
22,100
-1,000
-4% -$26K ﹤0.01% 1532
2021
Q3 		$768K Sell
23,100
-3,100
-12% -$95.9K ﹤0.01% 1295
2021
Q2 		$1.02M Sell
26,200
-7,300
-22% -$287K ﹤0.01% 1155
2021
Q1 		$1.61M Buy
33,500
+11,300
+51% +$543K 0.01% 838
2020
Q4 		$1.15M Buy
22,200
+6,600
+42% +$223K ﹤0.01% 969
2020
Q3 		$417K Buy
15,600
+10,900
+232% +$251K ﹤0.01% 1429
2020
Q2 		$91K Buy
+4,700
New +$75.7K ﹤0.01% 1813
2014
Q4 		– Sell
-11,400
Closed -$122K – 1802
2014
Q3 		$122K Buy
11,400
+6,100
+115% +$56.6K ﹤0.01% 1539
2014
Q2 		$50K Hold
5,300
– – ﹤0.01% 1622
2014
Q1 		$37K Hold
5,300
– – ﹤0.01% 1639
2013
Q4 		$21K Sell
5,300
-600
-10% -$2.42K ﹤0.01% 1702
2013
Q3 		$30K Hold
5,900
– – ﹤0.01% 1768
2013
Q2 		$38K Buy
+5,900
New +$37.8K ﹤0.01% 1765

Other funds holding TGTX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

STRS Ohio's TGTX Position: Q2 2026 in Review

STRS Ohio increased its TG Therapeutics (TGTX) stake by 124% in Q2 2026, buying an estimated $442K and bringing the position to 19,500 shares worth $1.07M. The position accounts for ﹤0.01% of the portfolio, ranked #703.

STRS Ohio first reported a position in TGTX in Q2 2013 and has held it in 27 quarters since. The position peaked at $1.61M in Q1 2021. 429 funds tracked by Wall St. Rank hold TGTX as of Q2 2026.

  • STRS Ohio held 19,500 shares of TG Therapeutics worth $1.07M as of Q2 2026.
  • STRS Ohio bought 10,800 TG Therapeutics shares in Q2 2026, an estimated $442K.
  • TG Therapeutics made up ﹤0.01% of STRS Ohio's portfolio in Q2 2026, its #703 holding.
  • STRS Ohio first reported a position in TG Therapeutics in Q2 2013 and has held it in 27 quarters since.
  • STRS Ohio's TG Therapeutics position peaked at $1.61M in Q1 2021.
  • 429 funds tracked by Wall St. Rank held TG Therapeutics as of Q2 2026.

Based on STRS Ohio's 13F filing for Q2 2026, filed 30 Jul 2026.